Switch to:
Also traded in: Germany, Mexico, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.45
SYK's Cash-to-Debt is ranked lower than
75% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.55 vs. SYK: 0.45 )
Ranked among companies with meaningful Cash-to-Debt only.
SYK' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.04  Med: 1.87 Max: N/A
Current: 0.45
Equity-to-Asset 0.47
SYK's Equity-to-Asset is ranked lower than
71% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. SYK: 0.47 )
Ranked among companies with meaningful Equity-to-Asset only.
SYK' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.22  Med: 0.65 Max: 0.78
Current: 0.47
0.22
0.78
Interest Coverage N/A
SYK's Interest Coverage is ranked higher than
73% of the 222 Companies
in the Global Medical Devices industry.

( Industry Median: 86.37 vs. SYK: N/A )
Ranked among companies with meaningful Interest Coverage only.
SYK' s Interest Coverage Range Over the Past 10 Years
Min: 24.66  Med: N/A Max: No Debt
Current: N/A
Piotroski F-Score: 4
Altman Z-Score: 4.74
Beneish M-Score: -2.05
WACC vs ROIC
5.30%
15.52%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 18.68
SYK's Operating Margin % is ranked higher than
88% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. SYK: 18.68 )
Ranked among companies with meaningful Operating Margin % only.
SYK' s Operating Margin % Range Over the Past 10 Years
Min: 12.88  Med: 20.21 Max: 23.92
Current: 18.68
12.88
23.92
Net Margin % 14.33
SYK's Net Margin % is ranked higher than
84% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 1.55 vs. SYK: 14.33 )
Ranked among companies with meaningful Net Margin % only.
SYK' s Net Margin % Range Over the Past 10 Years
Min: 5.32  Med: 15.59 Max: 17.39
Current: 14.33
5.32
17.39
ROE % 18.16
SYK's ROE % is ranked higher than
88% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 1.31 vs. SYK: 18.16 )
Ranked among companies with meaningful ROE % only.
SYK' s ROE % Range Over the Past 10 Years
Min: 5.84  Med: 18.18 Max: 21.28
Current: 18.16
5.84
21.28
ROA % 8.33
SYK's ROA % is ranked higher than
81% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 0.06 vs. SYK: 8.33 )
Ranked among companies with meaningful ROA % only.
SYK' s ROA % Range Over the Past 10 Years
Min: 3.12  Med: 10.96 Max: 15.38
Current: 8.33
3.12
15.38
ROC (Joel Greenblatt) % 71.39
SYK's ROC (Joel Greenblatt) % is ranked higher than
92% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 4.26 vs. SYK: 71.39 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
SYK' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 43.65  Med: 67.67 Max: 108.61
Current: 71.39
43.65
108.61
3-Year Revenue Growth Rate 8.20
SYK's 3-Year Revenue Growth Rate is ranked higher than
65% of the 237 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. SYK: 8.20 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
SYK' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 4.9  Med: 13.5 Max: 32.9
Current: 8.2
4.9
32.9
3-Year EBITDA Growth Rate 20.50
SYK's 3-Year EBITDA Growth Rate is ranked higher than
69% of the 208 Companies
in the Global Medical Devices industry.

( Industry Median: 5.10 vs. SYK: 20.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
SYK' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -9.6  Med: 16.8 Max: 59.8
Current: 20.5
-9.6
59.8
3-Year EPS without NRI Growth Rate 18.30
SYK's 3-Year EPS without NRI Growth Rate is ranked higher than
71% of the 203 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. SYK: 18.30 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
SYK' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -42.6  Med: 19.8 Max: 153
Current: 18.3
-42.6
153
GuruFocus has detected 7 Warning Signs with Stryker Corp $SYK.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» SYK's 30-Y Financials

Financials (Next Earnings Date: 2017-07-25 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

SYK Guru Trades in Q2 2016

Pioneer Investments 43,865 sh (+16.79%)
Jeremy Grantham 1,321,268 sh (+2.66%)
Vanguard Health Care Fund 2,498,900 sh (unchged)
PRIMECAP Management 295,500 sh (unchged)
Murray Stahl 2,000 sh (unchged)
George Soros Sold Out
Diamond Hill Capital 883,282 sh (-3.73%)
Paul Tudor Jones 3,700 sh (-11.90%)
Robert Olstein 38,000 sh (-15.56%)
Joel Greenblatt 63,965 sh (-25.47%)
Donald Yacktman 1,402,704 sh (-28.01%)
Yacktman Fund 1,100,000 sh (-31.25%)
» More
Q3 2016

SYK Guru Trades in Q3 2016

Louis Moore Bacon 4,820 sh (New)
Jeremy Grantham 1,385,768 sh (+4.88%)
Murray Stahl 2,000 sh (unchged)
Joel Greenblatt Sold Out
Pioneer Investments 42,064 sh (-4.11%)
Diamond Hill Capital 843,629 sh (-4.49%)
Yacktman Fund 1,000,000 sh (-9.09%)
Donald Yacktman 1,264,330 sh (-9.86%)
Paul Tudor Jones 3,200 sh (-13.51%)
Vanguard Health Care Fund 2,159,500 sh (-13.58%)
Robert Olstein 32,000 sh (-15.79%)
PRIMECAP Management 228,400 sh (-22.71%)
» More
Q4 2016

SYK Guru Trades in Q4 2016

Steven Cohen 337,600 sh (New)
Pioneer Investments 45,949 sh (+9.24%)
Diamond Hill Capital 919,621 sh (+9.01%)
Jeremy Grantham 1,470,782 sh (+6.13%)
PRIMECAP Management 228,400 sh (unchged)
Murray Stahl 2,000 sh (unchged)
Paul Tudor Jones Sold Out
Donald Yacktman 1,140,765 sh (-9.77%)
Yacktman Fund 900,000 sh (-10.00%)
Robert Olstein 28,500 sh (-10.94%)
Vanguard Health Care Fund 1,654,500 sh (-23.39%)
» More
Q1 2017

SYK Guru Trades in Q1 2017

Jim Simons 7,200 sh (New)
Joel Greenblatt 57,072 sh (New)
Caxton Associates 4,600 sh (New)
Pioneer Investments 58,469 sh (+27.25%)
PRIMECAP Management 228,400 sh (unchged)
Murray Stahl 2,000 sh (unchged)
Vanguard Health Care Fund 1,654,500 sh (unchged)
Louis Moore Bacon Sold Out
Diamond Hill Capital 898,655 sh (-2.28%)
Jeremy Grantham 1,150,968 sh (-21.74%)
Donald Yacktman 800,461 sh (-29.83%)
Yacktman Fund 600,000 sh (-33.33%)
Robert Olstein 19,000 sh (-33.33%)
Steven Cohen 176,800 sh (-47.63%)
» More
» Details

Insider Trades

Latest Guru Trades with SYK

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339112    SIC: 3841
Compare:NYSE:BSX, NAS:ISRG, NYSE:ABT, NYSE:ZBH, NYSE:EW, NYSE:STJ, NYSE:SNN, NAS:ALGN, OTCPK:SONVY, NYSE:TFX, NYSE:VAR, OTCPK:CNVVY, OTCPK:WILYY, OTCPK:CHEOY, NAS:ABMD, NAS:MASI, OTCPK:FSPKF, OTCPK:GGNDF, OTCPK:EKTAY, NAS:NUVA » details
Traded in other countries:SYK.Germany, SYK.Mexico, SYK.Switzerland, 0R2S.UK,
Headquarter Location:USA
Stryker Corp is a medical technology company. The Company offers medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products.

Stryker designs, manufactures, and markets an array of medical equipment, instruments, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Approximately 35% of Stryker's total revenue currently comes from outside the United States.

Top Ranked Articles about Stryker Corp

Answers to the Hardest Question: When Do I Sell a Stock? There are 2 primary reasons it makes sense to sell a stock
The most common complaint I have heard from investors over my 40-plus years in the financial services industry is as follows: "Everyone wants to tell me what to buy and when, but no one ever tells me when to sell." Read more...

Ratios

vs
industry
vs
history
PE Ratio 31.75
SYK's PE Ratio is ranked lower than
53% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 27.53 vs. SYK: 31.75 )
Ranked among companies with meaningful PE Ratio only.
SYK' s PE Ratio Range Over the Past 10 Years
Min: 11.3  Med: 24.99 Max: 71.37
Current: 31.75
11.3
71.37
Forward PE Ratio 22.03
SYK's Forward PE Ratio is ranked higher than
57% of the 111 Companies
in the Global Medical Devices industry.

( Industry Median: 21.79 vs. SYK: 22.03 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 31.75
SYK's PE Ratio without NRI is ranked lower than
53% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 27.51 vs. SYK: 31.75 )
Ranked among companies with meaningful PE Ratio without NRI only.
SYK' s PE Ratio without NRI Range Over the Past 10 Years
Min: 11.3  Med: 25.21 Max: 71.37
Current: 31.75
11.3
71.37
Price-to-Owner-Earnings 43.48
SYK's Price-to-Owner-Earnings is ranked lower than
56% of the 107 Companies
in the Global Medical Devices industry.

( Industry Median: 32.96 vs. SYK: 43.48 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
SYK' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 12.61  Med: 25.99 Max: 208.69
Current: 43.48
12.61
208.69
PB Ratio 5.43
SYK's PB Ratio is ranked lower than
73% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 3.11 vs. SYK: 5.43 )
Ranked among companies with meaningful PB Ratio only.
SYK' s PB Ratio Range Over the Past 10 Years
Min: 2.19  Med: 3.43 Max: 6.24
Current: 5.43
2.19
6.24
PS Ratio 4.54
SYK's PS Ratio is ranked lower than
64% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. SYK: 4.54 )
Ranked among companies with meaningful PS Ratio only.
SYK' s PS Ratio Range Over the Past 10 Years
Min: 1.93  Med: 3.35 Max: 5.29
Current: 4.54
1.93
5.29
Price-to-Free-Cash-Flow 45.11
SYK's Price-to-Free-Cash-Flow is ranked lower than
63% of the 112 Companies
in the Global Medical Devices industry.

( Industry Median: 27.61 vs. SYK: 45.11 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
SYK' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 11.66  Med: 19.92 Max: 102.33
Current: 45.11
11.66
102.33
Price-to-Operating-Cash-Flow 31.47
SYK's Price-to-Operating-Cash-Flow is ranked lower than
65% of the 140 Companies
in the Global Medical Devices industry.

( Industry Median: 20.26 vs. SYK: 31.47 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
SYK' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 10.23  Med: 17.11 Max: 55.28
Current: 31.47
10.23
55.28
EV-to-EBIT 25.78
SYK's EV-to-EBIT is ranked higher than
67% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 24.54 vs. SYK: 25.78 )
Ranked among companies with meaningful EV-to-EBIT only.
SYK' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.8  Med: 15 Max: 35.3
Current: 25.78
6.8
35.3
EV-to-EBITDA 20.30
SYK's EV-to-EBITDA is ranked higher than
67% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 19.31 vs. SYK: 20.30 )
Ranked among companies with meaningful EV-to-EBITDA only.
SYK' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.5  Med: 12.3 Max: 25.6
Current: 20.3
5.5
25.6
PEG Ratio 5.03
SYK's PEG Ratio is ranked lower than
69% of the 83 Companies
in the Global Medical Devices industry.

( Industry Median: 2.52 vs. SYK: 5.03 )
Ranked among companies with meaningful PEG Ratio only.
SYK' s PEG Ratio Range Over the Past 10 Years
Min: 0.51  Med: 1.73 Max: 76.24
Current: 5.03
0.51
76.24
Shiller PE Ratio 42.86
SYK's Shiller PE Ratio is ranked higher than
62% of the 50 Companies
in the Global Medical Devices industry.

( Industry Median: 49.41 vs. SYK: 42.86 )
Ranked among companies with meaningful Shiller PE Ratio only.
SYK' s Shiller PE Ratio Range Over the Past 10 Years
Min: 20.27  Med: 30.84 Max: 71.26
Current: 42.86
20.27
71.26
Current Ratio 3.09
SYK's Current Ratio is ranked higher than
52% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 2.38 vs. SYK: 3.09 )
Ranked among companies with meaningful Current Ratio only.
SYK' s Current Ratio Range Over the Past 10 Years
Min: 1.61  Med: 2.93 Max: 5.37
Current: 3.09
1.61
5.37
Quick Ratio 2.24
SYK's Quick Ratio is ranked higher than
51% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 1.79 vs. SYK: 2.24 )
Ranked among companies with meaningful Quick Ratio only.
SYK' s Quick Ratio Range Over the Past 10 Years
Min: 0.98  Med: 2.07 Max: 4.63
Current: 2.24
0.98
4.63
Days Inventory 182.43
SYK's Days Inventory is ranked lower than
69% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 130.04 vs. SYK: 182.43 )
Ranked among companies with meaningful Days Inventory only.
SYK' s Days Inventory Range Over the Past 10 Years
Min: 144.2  Med: 161.51 Max: 182.43
Current: 182.43
144.2
182.43
Days Sales Outstanding 58.07
SYK's Days Sales Outstanding is ranked higher than
59% of the 272 Companies
in the Global Medical Devices industry.

( Industry Median: 68.94 vs. SYK: 58.07 )
Ranked among companies with meaningful Days Sales Outstanding only.
SYK' s Days Sales Outstanding Range Over the Past 10 Years
Min: 58.07  Med: 61.84 Max: 63.4
Current: 58.07
58.07
63.4
Days Payable 41.38
SYK's Days Payable is ranked lower than
68% of the 259 Companies
in the Global Medical Devices industry.

( Industry Median: 59.71 vs. SYK: 41.38 )
Ranked among companies with meaningful Days Payable only.
SYK' s Days Payable Range Over the Past 10 Years
Min: 33.46  Med: 43.2 Max: 51.96
Current: 41.38
33.46
51.96

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.14
SYK's Dividend Yield % is ranked lower than
64% of the 191 Companies
in the Global Medical Devices industry.

( Industry Median: 1.33 vs. SYK: 1.14 )
Ranked among companies with meaningful Dividend Yield % only.
SYK' s Dividend Yield % Range Over the Past 10 Years
Min: 0.21  Med: 1.27 Max: 1.66
Current: 1.14
0.21
1.66
Dividend Payout Ratio 0.36
SYK's Dividend Payout Ratio is ranked higher than
70% of the 122 Companies
in the Global Medical Devices industry.

( Industry Median: 0.40 vs. SYK: 0.36 )
Ranked among companies with meaningful Dividend Payout Ratio only.
SYK' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.05  Med: 0.24 Max: 0.94
Current: 0.36
0.05
0.94
3-Year Dividend Growth Rate 12.50
SYK's 3-Year Dividend Growth Rate is ranked higher than
60% of the 81 Companies
in the Global Medical Devices industry.

( Industry Median: 8.00 vs. SYK: 12.50 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
SYK' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 20.4 Max: 81.9
Current: 12.5
0
81.9
Forward Dividend Yield % 1.20
SYK's Forward Dividend Yield % is ranked lower than
68% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 1.67 vs. SYK: 1.20 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 2.37
SYK's 5-Year Yield-on-Cost % is ranked higher than
59% of the 219 Companies
in the Global Medical Devices industry.

( Industry Median: 1.97 vs. SYK: 2.37 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
SYK' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.44  Med: 2.64 Max: 3.46
Current: 2.37
0.44
3.46
3-Year Average Share Buyback Ratio 0.30
SYK's 3-Year Average Share Buyback Ratio is ranked higher than
86% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. SYK: 0.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
SYK' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -0.8  Med: -0.2 Max: 1.9
Current: 0.3
-0.8
1.9

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 2.36
SYK's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
50% of the 129 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. SYK: 2.36 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
SYK' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.92  Med: 2.13 Max: 112.27
Current: 2.36
0.92
112.27
Price-to-Intrinsic-Value-DCF (Earnings Based) 2.97
SYK's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
76% of the 25 Companies
in the Global Medical Devices industry.

( Industry Median: 1.82 vs. SYK: 2.97 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.36
SYK's Price-to-Median-PS-Value is ranked lower than
70% of the 242 Companies
in the Global Medical Devices industry.

( Industry Median: 1.03 vs. SYK: 1.36 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
SYK' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.53  Med: 1.03 Max: 1.88
Current: 1.36
0.53
1.88
Price-to-Peter-Lynch-Fair-Value 3.79
SYK's Price-to-Peter-Lynch-Fair-Value is ranked lower than
86% of the 57 Companies
in the Global Medical Devices industry.

( Industry Median: 1.61 vs. SYK: 3.79 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
SYK' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.55  Med: 1.57 Max: 51.21
Current: 3.79
0.55
51.21
Earnings Yield (Greenblatt) % 3.88
SYK's Earnings Yield (Greenblatt) % is ranked higher than
79% of the 432 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. SYK: 3.88 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
SYK' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 2.8  Med: 6.65 Max: 14.6
Current: 3.88
2.8
14.6
Forward Rate of Return (Yacktman) % 10.73
SYK's Forward Rate of Return (Yacktman) % is ranked higher than
50% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 8.85 vs. SYK: 10.73 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
SYK' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -3.8  Med: 10.8 Max: 28.8
Current: 10.73
-3.8
28.8

More Statistics

Revenue (TTM) (Mil) $11,785
EPS (TTM) $ 4.45
Beta0.60
Short Percentage of Float1.44%
52-Week Range $106.48 - 141.59
Shares Outstanding (Mil)373.77

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 12,209 12,938 13,695
EPS ($) 6.42 7.07 7.81
EPS without NRI ($) 6.42 7.07 7.81
EPS Growth Rate
(Future 3Y To 5Y Estimate)
7.86%
Dividends per Share ($) 1.57 1.69 2.10
» More Articles for SYK

Headlines

Articles On GuruFocus.com
Goldman Sachs Rates Health Care Stocks May 17 2017 
Yacktman Fund Sells Viacom, Oracle, Microsoft Apr 18 2017 
6 Stocks That Beat the Market Oct 05 2016 
Healthcare Winners: Stryker Corp., UnitedHealth Group Inc. Aug 29 2016 
Johnson & Johnson Reports 4% Sales Growth for the Second Quarter Jul 22 2016 
Becton Dickinson: 19% EPS Growth With Good Dividends Jun 26 2016 
Answers to the Hardest Question: When Do I Sell a Stock? Jun 23 2016 
Weekly Insider Sells: Medivation, JPMorgan Chase, Stryker, Sabre Jan 26 2016 
Stryker: An Expensive Growth Play Dec 26 2015 
Louis Moore Bacon's Largest 3rd Quarter Trades Dec 23 2015 

More From Other Websites
Stryker (SYK) at 52-Week High: What's Driving the Stock? May 26 2017
Analysts Expect Medtronic’s Revenue to Rise 4% in Fiscal 4Q17 May 23 2017
ETFs with exposure to Stryker Corp. : May 22, 2017 May 22 2017
Stryker Orthopaedics 2016 Settlement Program reaches milestone May 08 2017
Stryker to participate in Bank of America Merrill Lynch 2017 Health Care Conference May 04 2017
The Zacks Analyst Blog Highlights: Kraft Heinz, Nike, Stryker, DISH Network, TD Ameritrade and... May 03 2017
Stryker declares a $0.425 per share quarterly dividend May 03 2017
Top Research Reports for Today: KHC, NKE, SYK & More May 02 2017
What Analysts Recommend for Stryker after 1Q17 Results May 02 2017
Stryker Corp. :SYK-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017 May 01 2017
What’s Stryker’s Guidance for 2017? May 01 2017
What Are Stryker’s Key Growth Drivers for 2Q17? May 01 2017
How Did Stryker’s Stock Perform after Its 1Q17 Results? May 01 2017
Edited Transcript of SYK earnings conference call or presentation 25-Apr-17 8:30pm GMT Apr 29 2017
Stryker Reported Strong Earnings in 1Q17 Apr 28 2017
Post Earnings Coverage as Stryker's Quarterly Net Sales Soared 18.8%; Adjusted EPS Jumped 19.4% Apr 28 2017
Stryker Sees Composite Rating Move Up To 98 Apr 27 2017
Stryker (SYK) Earnings and Revenues Beat Estimates in Q1 Apr 26 2017
Chipotle, Wynn, Arconic Beat; Stryker, Illumina Guide Q2 Profit Low Apr 25 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)